1. Home
  2. Faculty

Grant Bullock, MD, PhD

Clinical Associate Professor of Pathology

Current Positions

  • Clinical Associate Professor - Pathology

Education

  • B.S. with Highest Honors in Biochemistry, University of California, Davis
  • M.D., Carver College of Medicine, University of Iowa M.S.T.P.
  • Ph.D. in Molecular Biology, University of Iowa
  • Resident in Anatomic and Clinical Pathology, University of Virginia, Charlottesville
  • Fellowship in Hematopathology, University of Virginia, Charlottesville

Licenses & Certifications

  • Diplomate, American Board of Pathology, Clinical Pathology
  • Diplomate, American Board of Pathology, Hematology
  • State of Virginia Board of Medicine
  • State of Pennsylvania Board of Medicine

Selected Publications

  • Schrott, V, Bullock GC. Regulatory Role Of Mitochondrial Aconitase and Isocitrate In Iron-Responsive, Erythropoietin Receptor Signaling During Anemia Blood (ASH Annual Meeting Abstracts) 2013;122:3443.
  • Richardson CL, Bullock GC, Delehanty LL, Goldfarb AN. Targeting the Erythroid Iron Deprivation Response as a Therapeutic Approach In Anemia Not Caused by Iron Deficiency. Blood (ASH Annual Meeting Abstracts) 2010;116:166.
  • Talbot AL, Bullock GC, Delehanty LL, Goldfarb AN. RSK Inhibition Rescues Defective Erythropoiesis Caused by Blockade of Mitochondrial Aconitase. Blood (ASH Annual Meeting Abstracts). 2010;116:1008
  • Brix WK, Bullock GC, Haverstick DM, Seaner RM, Silverman LM, Mahadevan MS, Cousar JB. Detection of IgH Gene Rearrangements in Nodular Lymphocyte Predominant Hodgkin Lymphoma Using BIOMED-2® Primers. Modern Pathology. 2010;23:287A (Abstract 1290).
  • Bullock GC, Delehanty LL, Talbot AL, Gonias SL, Tong WH, Rouault T, Chruma J, Goldfarb AN. Iron and Isocitrate Calibrate Erythropoietin Responsiveness of Erythroid Progenitors Via Aconitase Tuning of Protein Kinase C Activity. Blood. (ASH Annual Meeting Abstracts). 2009;114:627.
  • Talbot AL, Bullock GC, Delehanty LL, Goldfarb AN. Aconitase Modulates Erythroid Signaling through a Novel MEK-ERK Regulatory Pathway. Blood. (ASH Annual Meeting Abstracts). 2009;114:75.
  • Richardson C, Bullock GC, Delehanty LL, Talbot AL, Elagib KE, Rubinstein J, Goldfarb AN. Synergy Between Specific Inflammatory Cytokines, IFN and TNF, and Iron Restriction in Erythroid Blockade: A New Model for Anemia of Chronic Disease. Blood. (ASH Annual Meeting Abstracts). 2009;114:159.
  • Bullock GC, Delehanty LL, Talbot AL, Richardson C, Goldfarb AN. In Vitro and In Vivo Abrogation of An Erythroid Iron Restriction Developmental Checkpoint by Isocitrate Through a Novel Erythropoietin Coupled Signaling Mechanism. Blood. 2008;112(11): 159.
  • Talbot AL, Bullock GC, Delehanty LL, Gonais SL, Goldfarb AN. Stage-Restricted, Non-Metabolic Function for Aconitase Enzymes in Erythropoietin Programming of Erythroid Growth and Differentiation in Vivo. Blood. 2008;112(11):1315.
  • Bullock GC, Delehanty LL, Gonais SL, Goldfarb AN. Iron Control of Erythropoiesis: A Novel Pathway in Which Aconitase Enzymes Couple Metabolic Flux with Cellular Development. Blood. 2007;110(11;part1):707.